Prostate News Archive
22-Nov-2008
Synta tests prostate-cancer therapy (Boston Business Journal)
Synta Pharmaceuticals Corp. treated the first patient in the clinical trial of its proprietary prostate-cancer drug elesclomol. Mechanisms of cardiovascular disease and cancer give clues to new therapies (EurekAlert!)
( European Science Foundation ) Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level. Swan unveils $7.5m prostate cancer fund (AAP via Yahoo!7 News)
Federal Treasurer Wayne Swan has drawn on his own battle with prostate cancer to announce a $7.5 million federal government grant. Diabetes drugs tied to lower prostate cancer risk (Scientific American)
NEW YORK (Reuters Health) - Drugs used to control diabetes may lower the risk of prostate cancer, investigators at the University of Tampere in Finland report. [More]
Back to Prostate News Archive
